CinCor Pharma, Inc

CinCor Pharma, Inc. (NASDAQ: CINC), relating to its proposed sale to AstraZeneca. Under the terms of the agreement, CINC shareholders are expected to receive $26.00 and one Contingent Value Right worth $10.00 in cash per share they own.

Amryt Pharma Plc

Amryt Pharma Plc (NASDAQ: AMYT), relating to its proposed sale to Chiesi Farmaceutici SpA. Under the terms of the agreement, AMYT shareholders are expected to receive $14.50 plus one Contingent Value Right of up to $2.50 per American Depositary Share they own.

IAA, Inc.

IAA, Inc. (NYSE: IAA), relating to its merger with Ritchie Bros. Auctioneers, Inc. Under the terms of the merger, IAA stockholders will receive $10.00 in cash and 0.5804 shares of Ritchie Bros. common stock per share they own.

Catalyst Biosciences, Inc.

Catalyst Biosciences, Inc. (NASDAQ: CBIO), relating to the proposed purchase of F351, a chemical entity owned by GNI Group Ltd.

Horizon Global Corp.

Horizon Global Corp. (NYSE: HZN), relating to its proposed sale to First Brands Group. Under the terms of the agreement, HZN shareholders are expected to receive $1.75 in cash per share they own.

Maxar Technologies, Inc.

Maxar Technologies, Inc. (NYSE: MAXR), relating to its proposed sale to Advent International. Under the terms of the agreement, MAXR shareholders are expected to receive $53.00 in cash per share they own.

IsoPlexis Corp.

IsoPlexis Corp. (NASDAQ: ISO), relating to its proposed sale to Berkeley Lights, Inc. Under the terms of the agreement, ISO shareholders are expected to receive 0.612 shares of Berkeley per share they own.

Qumu Corp.

Qumu Corp. (NASDAQ: QUMU), relating to its proposed sale to Enghouse Systems Ltd. Under the terms of the agreement, QUMU shareholders are expected to receive $0.90 in cash per share they own.

Trean Insurance Group, Inc

Trean Insurance Group, Inc. (NASDAQ: TIG), relating to its proposed acquisition by affiliates of Altaris, LLC. Under the terms of the agreement, TIG shareholders are expected to receive $6.15 in cash per share they own.

Brunswick Bancorp

Brunswick Bancorp (OTC: BRBW), relating to its proposed acquisition by Mid Penn Bancorp, Inc. Under the terms of the agreement, BRBW shareholders are expected to receive either 0.598 shares of Mid Penn common stock or $18.00 in cash per share they own.